Cancer Research Cell Death Mechanisms and Cancer Therapy Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Cancer Research 67, 876, February 1, 2007. doi: 10.1158/0008-5472.CAN-06-2995
© 2007 American Association for Cancer Research
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bollati, V.
Right arrow Articles by Yang, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bollati, V.
Right arrow Articles by Yang, A. S.

Priority Reports

Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene

Valentina Bollati1, Andrea Baccarelli1,2, Lifang Hou3, Matteo Bonzini1, Silvia Fustinoni1, Domenico Cavallo4, Hyang-Min Byun5, Jiayi Jiang5, Barbara Marinelli1, Angela C. Pesatori1, Pier A. Bertazzi1 and Allen S. Yang5

1 Molecular Epidemiology Laboratory, Department of Environmental and Occupational Health, University of Milan and Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Ospedale Maggiore Policlinico, Milan, Italy; 2 Exposure, Epidemiology, and Risk Program, Harvard School of Public Health, Boston, Massachusetts; 3 Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; 4 Department of Chemistry and Environmental Sciences, University of Insubria, Como, Italy; and 5 Division of Hematology, Keck School of Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California

Requests for reprints: Valentina Bollati, Center of Molecular Epidemiology and Genetics, Department of Environmental and Occupational Health, University of Milan, Via San Barnaba 8, 20122 Milan, Italy. Phone: 39-02-503-20127; Fax: 39-02-503-20103; E-mail: valentina.bollati{at}unimi.it.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Aberrant DNA methylation patterns, including global hypomethylation, gene-specific hypermethylation/hypomethylation, and loss of imprinting (LOI), are common in acute myelogenous leukemia (AML) and other cancer tissues. We investigated for the first time whether such epigenetic changes are induced in healthy subjects by low-level exposure to benzene, a widespread pollutant associated with AML risk. Blood DNA samples and exposure data were obtained from subjects with different levels of benzene exposure, including 78 gas station attendants, 77 traffic police officers, and 58 unexposed referents in Milan, Italy (personal airborne benzene range, <6–478 µg/m3). Bisulfite-PCR pyrosequencing was used to quantitate DNA methylation in long interspersed nuclear element-1 (LINE-1) and AluI repetitive elements as a surrogate of genome-wide methylation and examine gene-specific methylation of MAGE-1 and p15. Allele-specific pyrosequencing of the H19 gene was used to detect LOI in 96 subjects heterozygous for the H19 imprinting center G/A single-nucleotide polymorphism. Airborne benzene was associated with a significant reduction in LINE-1 (–2.33% for a 10-fold increase in airborne benzene levels; P = 0.009) and AluI (–1.00%; P = 0.027) methylation. Hypermethylation in p15 (+0.35%; P = 0.018) and hypomethylation in MAGE-1 (–0.49%; P = 0.049) were associated with increasing airborne benzene levels. LOI was found only in exposed subjects (4 of 73, 5.5%) and not in referents (0 of 23, 0.0%). However, LOI was not significantly associated with airborne benzene (P > 0.20). This is the first human study to link altered DNA methylation, reproducing the aberrant epigenetic patterns found in malignant cells, to low-level carcinogen exposure. [Cancer Res 2007;67(3):876–80]


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Exposure to benzene, a widespread airborne pollutant emitted from traffic exhaust fumes and cigarette smoking, has been consistently associated with acute myelogenous leukemia (AML), but the mechanisms relating benzene to AML risk are still unclear (1). Aberrant DNA methylation patterns, including global hypomethylation, gene-specific hypermethylation or hypomethylation, and loss of imprinting (LOI), are common in AML and other cancer tissues. Global genomic DNA methylation levels tend to decrease in each step of the progression from normal to AML cells as also shown for other cancers (2). Gene-specific hypomethylation has also been reported in cancer cells, including decreased methylation of MAGE-1, a gene hypomethylated in malignant cells (3, 4). In AML, gene-specific hypermethylation shows a specific pattern, including frequent methylation and inactivation of the p15 tumor suppressor gene (5, 6). DNA methylation is responsible for imprinting in mammal cells or at least reflects the imprinted state of a locus produced during gametogenesis that causes specific genes to be expressed either by the paternally or maternally inherited chromosome. LOI represents an early epigenetic event in leukemogenesis that was found in blood from subjects with AML and myelodysplastic syndrome but not in blood or hematopoietic progenitor cells from normal individuals (7).

In the present study, we investigated the effects of low-dose benzene exposure on DNA methylation using peripheral blood DNA from subjects with well-characterized benzene exposure (8). The investigation was designed to evaluate (a) DNA methylation changes in AluI and long interspersed nuclear element-1 (LINE-1) repetitive elements as a surrogate of genome-wide methylation, (b) promoter methylation of p15 and MAGE-1, and (c) changes in allele-specific methylation of H19 to detect LOI.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Subjects and Exposure Assessment
The study included 78 gasoline filling attendants and 77 urban traffic officers exposed to low-benzene levels in Milan, Italy (8). Fifty-seven office workers from the same area, frequency matched by gender, age, and smoking to the exposed groups, were used as referents (Table 1 ). Personal exposure to airborne benzene was higher in gas station attendants than in traffic officers, whereas levels were lowest in the reference group (Table 1). Benzene exposure was determined by a passive sampler (stainless steel tube, internal diameter of 9 mm, length of 90 mm) containing Chromosorb 106, worn by the study subjects near the breathing zone during the work shift. Benzene was determined by thermal desorption followed by gas chromatography/flame ionization detector analysis. Written informed consent was obtained from the study subjects, and approval was granted by the local Institutional Review Board.


View this table:
[in this window]
[in a new window]

  		Table 1. Characteristics and airborne benzene concentrations in the referent and benzene-exposed groups

 
Bisulfite Treatment
DNA (1 µg) was denatured in 50 µL of 2 mol/L NaOH for 20 min at 37°C. Then, 30 µL of freshly prepared 10 mmol/L hydroquinone and 520 µL of 3 mol/L sodium bisulfite (Sigma-Aldrich, St. Louis, MO) at pH 5.0 were added and mixed. The samples were incubated at 50°C for 16 h. The bisulfite-treated DNA was isolated using Wizard DNA Clean-Up System (Promega, Madison, WI). The DNA was eluted by 50 µL of warm water, and 5.5 µL of 3 mol/L NaOH were added for 5 min. The DNA was ethanol precipitated with glycogen as a carrier and resuspended in 20 µL water. Bisulfite-treated DNA was stored at –20°C until use.

PCR and Pyrosequencing
DNA methylation was quantitated using bisulfite-PCR and pyrosequencing (9). In brief, the samples were bisulfite treated and PCR amplified (see Table 2 for PCR primers and conditions). A biotin-labeled primer was used to purify the final PCR product using Sepharose beads. The PCR product was bound to Streptavidin Sepharose High Performance (Amersham Biosciences, Uppsala, Sweden), and the Sepharose beads containing the immobilized PCR product were purified, washed, denatured using a 0.2 mol/L of NaOH solution, and washed again using the Pyrosequencing Vacuum Prep Tool (Pyrosequencing, Inc., Westborough, MA) as per the manufacturer's recommendations. Then, 0.3 µmol/L of pyrosequencing primer was annealed to the purified single-stranded PCR product and pyrosequencing was done using the PSQ HS96 Pyrosequencing System (Pyrosequencing). The degree of methylation was expressed for each DNA locus as percentage methylated cytosines over the sum of methylated and unmethylated cytosines. We used non-CpG cytosine residues as built-in controls to verify bisulfite conversion. Each marker was tested in three replicates and their average was used in the statistical analysis.


View this table:
[in this window]
[in a new window]

  		Table 2. Primers and PCR conditions for DNA methylation analyses

 
Repetitive elements AluI and LINE-1. AluI and LINE-1 element PCR was used for pyrosequencing-based methylation analysis using previously published methods (10) with the following modifications. A 25 µL PCR was carried out in 10 µL Eppendorf HotMaster Taq DNA kit (Eppendorf, Westbury, NY), 1 pmol biotinylated forward primer, 1 pmol reverse primer, 50 ng bisulfite-treated genomic DNA, and water.

MAGE-1 and p15. To measure methylation of the MAGE-1 and p15 promoters, a 25 µL PCR was carried out in 10 µL Eppendorf HotMaster Taq DNA kit, 10 pmol forward primer, 10 pmol reverse primer, 50 ng bisulfite-treated genomic DNA, and water.

H19 (LOI Assay)
H19 allele-specific methylation was done as a surrogate marker of LOI. An article describing this newly developed technique is under consideration (11). This technology relies on two individual primers that are directed against one allele but not the other of a single-nucleotide polymorphism (SNP) so that nucleotide extension analysis by pyrosequencing can be done on each allele individually. Briefly, the protocol involves bisulfite treatment of DNA, PCR amplification, and then pyrosequencing of the CTCF-binding domain using allele-specific primers.

H19 genotyping. First, heterozygosity for the G/A SNP within the H19 imprinting center (rs2071094; dbSNP build 124; Genbank AF125183, nucleotide 8008) was determined by pyrosequencing. A 135-bp region was amplified on human genomic DNA with the PCR primers 5'-GGTCTCACCGCCTGGATC-3' and 5'-biotin-GACCCGGGACGTTTCCAC-3' and genotyped with the sequencing primer 5'-ACAGCCCGAGCCCGC-3' using standard pyrosequencing.

LOI assay. A nested PCR was done on DNA from heterozygote subjects. Bisulfite-modified DNA (2 µL) was amplified in a primary PCR followed by a second nested PCR using 1 µL of the primary PCR product. PCR was done in 25 µL volume using 10 pmol of each primer and the Eppendorf HotMaster Taq DNA kit at reagent concentrations as per the manufacturer's instructions.

Statistical Analysis
Student's t test and ANOVA were used to test for differences in methylation levels by categorical variables. We used linear regression analysis to assess the association of logarithmic airborne benzene, or other continuous variables, with DNA methylation. All statistical tests were two sided.


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
DNA methylation by occupational groups. LINE-1 methylation was lower in the benzene-exposed subjects compared with the referents (Table 3 ). The average percentage of methylated cytosines in LINE-1 sequences was 62.2% (SD, 6.6) in gas station attendants, 62.3% (SD, 6.5) in traffic officers, and 65.7% (SD, 5.2) in referents (P = 0.003 for differences among the occupational groups). AluI methylation showed a moderate nonsignificant decrease in gas station attendants (mean, 26.4%; SD, 2.5), with no change in traffic officers (mean, 27.5%; SD, 3.9), compared with referents (mean, 27.3%; SD, 3.4; P = 0.12).


View this table:
[in this window]
[in a new window]

  		Table 3. Methylation levels (Cm%) of global and gene-specific methylation markers in the exposed groups (urban traffic officers and gas station attendants) compared with referent subjects (office workers)

 
Gene-specific analysis showed low p15 methylation in the referent group (mean, 1.2; SD, 0.9) that increased significantly in traffic officers (mean, 2.0; SD, 1.0) and gas station attendants (mean, 2.0; SD, 1.2; P < 0.001). MAGE-1 was highly methylated and showed no differences in the three groups (Table 3).

DNA methylation and airborne benzene exposure. LINE-1 and AluI methylation decreased with increasing airborne benzene exposure levels (Fig. 1A and B ). This decrease, estimated for a 10-fold increase in airborne benzene, was equal to 2.33% [95% confidence interval (95% CI), –4.06 to –0.60; P = 0.009] for LINE-1 and 1.00% (95% CI, –1.87 to –0.11; P = 0.027) for AluI.


Figure 1
View larger version (31K):
[in this window]
[in a new window]
[Download PPT slide]
  		Figure 1. Subjects' airborne benzene exposure associated with LINE-1 (A) or AluI (B) sequences used as a surrogate for global methylation and gene-specific methylation of p15 (C) and MAGE-1 (D). Individual data points and univariate regression lines. Coefficients represent the change in percentage methylated cytosines estimated for a 10-fold increase in airborne benzene concentrations.

 
Airborne benzene was associated with increased methylation in p15 (+0.35%; 95% CI, 0.06–0.64; P = 0.018; Fig. 1C). MAGE-1 exhibited decreased methylation (Fig. 1D), but the association with airborne benzene was borderline significant (–0.49%; 95% CI, –0.96 to –0.00; P = 0.049).

In multivariable regression analyses, the estimated changes in DNA methylation did not differ when several combinations of possible confounders, including age, sex, smoking (never, ex, and current), urine cotinine, cigarettes/day, pack-years, years since smoking cessation, alcohol, metabolic polymorphisms (NQO1 and CYP2E1), and percentage lymphocytes in the differential count (data not shown).

DNA methylation exhibited no consistent association with smoking status, number of cigarettes/day, urinary cotinine, pack-years, and years from smoking cessation (P > 0.05 for all DNA sequences considered). Notably, AluI methylation exhibited a borderline negative correlation with pack-years of smoking (r = –0.13%; P = 0.06).

Loss of imprinting. We determined allele-specific DNA methylation of H19 as a marker for LOI. Because this assay is applicable only to subjects who are heterozygotes in the H19 G/A SNP (rs2071094; dbSNP build 124) used for allele-specific detection, only 96 subjects who had the G/A genotype were available for this test. We estimated the average methylation of the methylated allele (mean, 74.5%; SD, 20.5), of the unmethylated allele (mean, 2.85%; SD, 4.62), and of their difference (mean, 71.7%; SD, 21.9). None of these quantities was associated with airborne benzene (P > 0.20). We identified, however, four subjects that showed aberrant methylation patterns. Three of them showed both an increase of methylation in the unmethylated allele and a decrease in the methylated allele (subject 1: methylated, 22.9% and unmethylated, 9.0%; subject 2: methylated, 17.6% and unmethylated, 9.3%; subject 3: methylated, 25.2% and unmethylated, 12.1%). One more subject had one normally unmethylated allele with a large decrease in methylation of the methylated allele (subject 4: methylated, 16.5% and unmethylated, 0%). All of these four subjects were in the benzene-exposed groups, with airborne benzene levels equal to 34, 276, 47, and 28 µg/m3, respectively.


   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
In vitro and animal studies have shown that carcinogenic agents induce DNA methylation changes in normal tissues similar to those found in malignant cells (12–15). In our study, we observed DNA methylation alterations in subjects exposed to low-level airborne benzene that were qualitatively comparable with those observed in AML and other malignancies. To the best of our knowledge, this is the first study in humans to link altered DNA methylation patterns to exposure to any carcinogen at levels that are common in Western countries.

We used DNA methylation analyses of LINE-1 and AluI repeated sequences to evaluate global methylation. Due to the heavy methylation of repetitive elements, these assays, which are easier to do than previous methods to quantitate total genomic 5-methylcytosine, can detect decreases in DNA methylation and serve as a surrogate for global methylation (10). Our results showed an exposure-related decrease in the methylation of LINE-1 and AluI repeated sequences. This observation is consistent with the global hypomethylation frequently observed in AML and other malignant cells, which has been linked to higher chromosomal instability and aberrant activation of cellular genes (2). The alterations we observed were small in size and may represent an early deviation induced by the exposure from normal methylation patterns.

In our study, p15 promoter methylation in exposed individuals was nearly twice as high as that observed in the referent unexposed subjects. AML is one of the few neoplasms that show hypermethylation of p15, likely contributing to deregulated cell proliferation (5). The p15 promoter shows low or no methylation in normal cells and is hypermethylated as the cell progresses through the multistep process leading to the development of the full malignant phenotype (5, 16). MAGE-1, which is usually heavily methylated in normal tissues, tended to exhibit lower methylation in association with airborne benzene levels in our study. This finding may indicate the initial activation of biological processes in exposed subjects, potentially preceding the profound MAGE-1 hypomethylation observed in several tumors of various histologic types, including leukemias (3, 4).

LOI, also diffusely seen in malignant cells, was not significantly associated with benzene exposure in our study. Our LOI assay allows for the determination of LOI only in H19 heterozygote subjects, thus limiting the statistical power for this analysis. However, the finding that changes in allele-specific methylation were present in four exposed subjects and no controls warrants further investigations.

Our study was based on quantitative analysis of DNA methylation using pyrosequencing methodology, which is highly reproducible and accurate at measuring small changes in DNA methylation. DNA methylation analysis was repeated thrice on each sample to minimize the assay variability.

The mechanism by which benzene interferes with DNA methylation remains unclear. Benzene enhances nitric oxide production in the bone marrow, possibly inducing a posttranscriptional increase in the activity of DNA methyltransferases (17). In addition, reactive oxygen species and oxidative DNA damage produced by benzene may reduce binding affinity of the methyl-CpG binding protein 2, thereby resulting in epigenetic alterations (18). At the same time, DNA strand breaks induced by benzene exposure may cause DNA methyltransferases to bind with higher affinity at specific sites (19).

Some of our findings open further questions warranting future investigation. LINE-1 element methylation changes had a stronger correlation with benzene exposure than AluI repetitive elements. Hypothetically, this could be explained as methylation of LINE-1 and AluI is controlled through different mechanisms (20). Alternatively, the lower concentration of CpG sites in AluI elements may result in lower sensitivity for the use of AluI methylation as a global DNA methylation marker. We found no consistent association of DNA methylation with smoking, which is the largest source of benzene in subjects without occupational exposure. However, tobacco smoke is a mixture of a high number of agents with complex synergic effects that could level off the effect due to tobacco-derived benzene. In addition, multivariable models indicated that smoking was not a confounder of the relation between benzene and DNA methylation.

In spite of the clear dose-response relationship between DNA methylation and airborne benzene, indicating that benzene exposure was the main factor responsible for DNA methylation changes in our study, we cannot exclude that other traffic pollutants, including particulate matter, polycyclic aromatic hydrocarbons, CO, SO2, NO2, toluene, or xylene, may have contributed to the observed changes.

In conclusion, our study showed for the first time that low-level benzene exposure is associated in normal subjects with DNA methylation changes that reproduce the aberrant epigenetic patterns found in malignant cells. Additional studies are required to better define the mechanisms by which benzene and other carcinogens produce such alterations.


   Acknowledgments
 
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 8/21/06. Revised 10/ 9/06. Accepted 11/30/06.


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. International Agency for Research on Cancer. Overall evaluations of carcinogenicity: an updating of IARC monographs volumes 1 to 42. IARC Monogr Eval Carcinog Risks Hum Suppl 1987;7:1–440.[Medline]
  2. Lubbert M, Oster W, Ludwig WD, Ganser A, Mertelsmann R, Herrmann F. A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias. Blood 1992;80:2066–73.[Abstract/Free Full Text]
  3. Greiner J, Ringhoffer M, Simikopinko O, et al. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 2000;28:1413–22.[CrossRef][Medline]
  4. Chambost H, Brasseur F, Coulie P, et al. A tumour-associated antigen expression in human haematological malignancies. Br J Haematol 1993;84:524–6.[Medline]
  5. Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic malignancies. Blood Rev 2006;20:1–13.[CrossRef][Medline]
  6. Melki JR, Vincent PC, Clark SJ. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999;59:3730–40.[Abstract/Free Full Text]
  7. Zumkeller W. The insulin-like growth factor system in hematopoietic cells. Leuk Lymphoma 2002;43:487–91.[CrossRef][Medline]
  8. Fustinoni S, Consonni D, Campo L, et al. Monitoring low benzene exposure: comparative evaluation of urinary biomarkers, influence of cigarette smoking, and genetic polymorphisms. Cancer Epidemiol Biomarkers Prev 2005;14:2237–44.[Abstract/Free Full Text]
  9. England RPM. Pyro Q-CpGTM: quantitative analysis of methylation in multiple CpG sites by Pyrosequencing®. Nature Methods 2005;2:1–2.
  10. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res 2004;32:e38.[Abstract/Free Full Text]
  11. Wong HL, Byun HM, Kwan JM, et al. Rapid and quantitative method of allele-specific DNA methylation analysis. Biotechniques 2006;41:734–9.[Medline]
  12. Poirier LA, Vlasova TI. The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ Health Perspect 2002;110 Suppl 5:793–5.
  13. Chen H, Li S, Liu J, Diwan BA, Barrett JC, Waalkes MP. Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis. Carcinogenesis 2004;25:1779–86.[Abstract/Free Full Text]
  14. Belinsky SA, Snow SS, Nikula KJ, Finch GL, Tellez CS, Palmisano WA. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis 2002;23:335–9.[Abstract/Free Full Text]
  15. Wilson VL, Jones PA. Inhibition of DNA methylation by chemical carcinogens in vitro. Cell 1983;32:239–46.[CrossRef][Medline]
  16. Claus R, Lubbert M. Epigenetic targets in hematopoietic malignancies. Oncogene 2003;22:6489–96.[CrossRef][Medline]
  17. Laskin DL, Heck DE, Punjabi CJ, Laskin JD. Role of nitric oxide in hematosuppression and benzene-induced toxicity. Environ Health Perspect 1996;104 Suppl 6:1283–7.
  18. Valinluck V, Tsai HH, Rogstad DK, Burdzy A, Bird A, Sowers LC. Oxidative damage to methyl-CpG sequences inhibits the binding of the methyl-CpG binding domain (MBD) of methyl-CpG binding protein 2 (MeCP2). Nucleic Acids Res 2004;32:4100–8.[Abstract/Free Full Text]
  19. James SJ, Pogribny IP, Pogribna M, Miller BJ, Jernigan S, Melnyk S. Mechanisms of DNA damage, DNA hypomethylation, and tumor progression in the folate/methyl-deficient rat model of hepatocarcinogenesis. J Nutr 2003;133:3740–7S.
  20. Gonzalgo ML, Jones PA. Mutagenic and epigenetic effects of DNA methylation. Mutat Res 1997;386:107–18.[CrossRef][Medline]



This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
H.-M. Byun, K. D. Siegmund, F. Pan, D. J. Weisenberger, G. Kanel, P. W. Laird, and A. S. Yang
Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns
Hum. Mol. Genet., December 15, 2009; 18(24): 4808 - 4817.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. M. Patel and R. L. Miller
Rapid DNA Methylation Changes after Exposure to Traffic Particles: The Issue of Spatio-Temporal Factors
Am. J. Respir. Crit. Care Med., November 15, 2009; 180(10): 1030 - 1030.
[Full Text] [PDF]

Home page
 Occup. Environ. Med.Home page
P Brosselin, J Rudant, L Orsi, G Leverger, A Baruchel, Y Bertrand, B Nelken, A Robert, G Michel, G Margueritte, et al.
Acute childhood leukaemia and residence next to petrol stations and automotive repair garages: the ESCALE study (SFCE)
Occup. Environ. Med., September 1, 2009; 66(9): 598 - 606.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Zhou, J. K. Kepa, D. Siegel, S. Miura, Y. Hiraki, and D. Ross
Benzene Metabolite Hydroquinone Up-Regulates Chondromodulin-I and Inhibits Tube Formation in Human Bone Marrow Endothelial Cells
Mol. Pharmacol., September 1, 2009; 76(3): 579 - 587.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
V. Bollati, S. Fabris, V. Pegoraro, D. Ronchetti, L. Mosca, G. L. Deliliers, V. Motta, P. A. Bertazzi, A. Baccarelli, and A. Neri
Differential repetitive DNA methylation in multiple myeloma molecular subgroups
Carcinogenesis, August 1, 2009; 30(8): 1330 - 1335.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
D. Desaulniers, G.-h. Xiao, H. Lian, Y.-L. Feng, J. Zhu, J. Nakai, and W. J. Bowers
Effects of Mixtures of Polychlorinated Biphenyls, Methylmercury, and Organochlorine Pesticides on Hepatic DNA Methylation in Prepubertal Female Sprague-Dawley Rats
International Journal of Toxicology, July 1, 2009; 28(4): 294 - 307.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
T. S. Nawrot and I. Adcock
The Detrimental Health Effects of Traffic-related Air Pollution: A Role for DNA Methylation?
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 523 - 524.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. Baccarelli, R. O. Wright, V. Bollati, L. Tarantini, A. A. Litonjua, H. H. Suh, A. Zanobetti, D. Sparrow, P. S. Vokonas, and J. Schwartz
Rapid DNA Methylation Changes after Exposure to Traffic Particles
Am. J. Respir. Crit. Care Med., April 1, 2009; 179(7): 572 - 578.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
H. Kroeger, J. Jelinek, M. R. H. Estecio, R. He, K. Kondo, W. Chung, L. Zhang, L. Shen, H. M. Kantarjian, C. E. Bueso-Ramos, et al.
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Blood, August 15, 2008; 112(4): 1366 - 1373.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bollati, V.
Right arrow Articles by Yang, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bollati, V.
Right arrow Articles by Yang, A. S.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online